NCT03326648

Brief Summary

The purpose of this study is to investigate mechanisms underlying the reduction in muscle quality (the ratio between muscle strength and muscle size) with aging, and to investigate how these factors are affected by strength training and protein supplementation. It is already established that muscle quality defined as the ratio between the strength and the size of a muscle is improved with strength training, even in frail elderly individuals. However, the relative contribution of factors such as activation level, fat infiltration, muscle architecture and single fiber function is unknown. The main focus of this study is to investigate the relationship between muscle quality and muscle protein breakdown, as insufficient degradation of proteins is hypothesized to negatively affect muscle quality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 5, 2017

Completed
6 months until next milestone

First Posted

Study publicly available on registry

October 31, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

April 11, 2018

Status Verified

April 1, 2018

Enrollment Period

1.3 years

First QC Date

May 5, 2017

Last Update Submit

April 10, 2018

Conditions

Keywords

SarcopeniaFrailtyStrength trainingAutophagy

Outcome Measures

Primary Outcomes (1)

  • Single fiber specific force

    A measure of muscle quality at the single fiber level. Biopsies obtained from m. Vastus Lateralis

    Change from baseline at 10 weeks

Secondary Outcomes (51)

  • Lean mass

    Change from baseline at 10 weeks

  • Fat mass

    Change from baseline at 10 weeks

  • Bone mineral density

    Change from baseline at 10 weeks

  • Muscle strength of m. quadriceps

    Change from baseline at 10 weeks

  • Muscle size of m. quadriceps

    Change from baseline at 10 weeks

  • +46 more secondary outcomes

Study Arms (2)

Strength training + protein supplement

EXPERIMENTAL

Two sessions of strength training each week in addition to daily protein supplementation for 10 weeks.

Other: Strength trainingDietary Supplement: Protein supplementation

Protein supplement

EXPERIMENTAL

Daily protein supplementation for 10 weeks.

Dietary Supplement: Protein supplementation

Interventions

Heavy load strength training performed twice a week for 10 weeks.

Also known as: Resistance training
Strength training + protein supplement
Protein supplementationDIETARY_SUPPLEMENT

Dietary protein supplement (protein-enriched milk with 0,2 % fat). 0,33 l each day for 10 weeks.

Protein supplementStrength training + protein supplement

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age \> 65
  • Frail or pre-frail according to the Fried Frailty Criteria or Short Physical Performance Battery (SPPB) score \<6.
  • Mini Mental State Examination score \> 18

You may not qualify if:

  • Diseases or injuries contraindicating participation
  • Lactose intolerance
  • Allergy to milk
  • Allergy towards local anesthetics (xylocain)
  • Use of anticoagulants that cannot be discontinued prior to the muscle biopsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Norwegian School of Sport Sciences

Oslo, 0863, Norway

Location

MeSH Terms

Conditions

SarcopeniaFrailty

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsPathologic Processes

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Truls Raastad, Prof.

    Norwegian School of Sport Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Subjects and testers will not be blinded. All analyses of muscle samples will be performed blinded.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

May 5, 2017

First Posted

October 31, 2017

Study Start

September 1, 2016

Primary Completion

December 20, 2017

Study Completion

March 1, 2018

Last Updated

April 11, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations